rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Minerva Neurosciences, Inc

NERV · Nasdaq

Health CareBiotechnologyNot moving yet

NERV stood above a rising 150-day average in 31 of the last 52 weekly readings, and has been out of that trend for the last 16 weeks. It is 51.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 16
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
58 (+15)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders58+15 on the quarter
New · exited24 · 9
Reported value$235.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FEDERATED HERMES, INC.reduced · filed 12 Aug 20264,670,426$25.9M-442,798−8.7%
Jupiter Topco LLCnew · filed 14 Aug 20264,386,027$24.3M+4,386,027
Vivo Capital, LLCunchanged · filed 14 Aug 20264,322,747$24.0M00.0%
Balyasny Asset Management L.P.reduced · filed 14 Aug 20264,257,000$23.6M-1,6000.0%
Logos Global Management LPadded · filed 14 Aug 20263,288,777$18.3M+73,777+2.3%
FARALLON CAPITAL MANAGEMENT, L.L.C.unchanged · filed 14 Aug 20262,365,000$13.1M00.0%
BlackRock, Inc.added · filed 7 Aug 20262,240,578$12.4M+1,615,721+258.6%
Ally Bridge Group (NY) LLCadded · filed 14 Aug 20262,175,802$12.1M+520,302+31.4%
Foresite Capital Management VI LLCreduced · filed 14 Aug 20261,985,584$11.0M-1,016−0.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,892,807$10.5M+46,976+2.5%
31 Mar 2023 – 30 Jun 2026
133556Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Inderjit Kaul Company insiderDirector · last 3 Aug 20260 · 0
David Kupfer Company insiderDirector · last 3 Jun 20264 · 1
Fouzia Laghrissi-Thode Company insiderDirector · last 3 Jun 20260 · 0
Frederick W. Ahlholm Company insiderSVP, CFO and Secretary · last 3 Jun 20261 · 8
G. Jan Van Heek Company insiderDirector · last 3 Jun 20263 · 0
Hans Peter Hasler Company insiderDirector · last 3 Jun 20261 · 0
Remy Luthringer Company insiderCEO · last 3 Jun 20260 · 8
James Joseph O'Connor Company insiderChief Business Officer and GC · last 21 Apr 20260 · 0
Geoff Race Company insiderPresident · last 22 Dec 20251 · 7
Jeryl L. Hilleman Company insiderDirector · last 27 Sep 20231 · 0
William F. Doyle Company insiderDirector · last 10 Jun 202211 · 0
Joseph H. Reilly Company insiderSVP & Chief Operating Officer · last 16 Dec 20201 · 7

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-15.8%
Share count trendFY 2025 · to 6 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$82.3M

Analyst forecasts

No analyst forecasts yet.